IXHL Incannex Healthcare Inc.
3.180USD+0.32%Mkt Cap: 39.89M $P/E: —1d ago
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops I…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.23BUSDP/E 25.7
$58.68BUSD
$45.70BUSDP/E 65.3
GALD
Galderma Group AG$43.27BUSDP/E 56.1
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG$34.93BUSDP/E 60.5
HLN
Haleon plc$32.73BUSDP/E 19.0
$28.56BUSDP/E 12.2
$29.57BUSDP/E 11.8
$23.38BUSDP/E 19.5
$20.09BUSD
$14.43BUSDP/E 112.9
$14.58BUSDP/E 21.0
$12.99BUSDP/E 23.5
$11.17BUSD
$10.22BUSDP/E 27.9
$8.66BUSDP/E 19.3
$6.95BUSDP/E 109.1
$6.89BUSD
$6.84BUSDP/E 40.1
| Headline | Source | Time |
|---|---|---|
Older | ||
 Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X Incannex Healthcare Inc. (NASDAQ:IXHL) is one of the best strong buy penny stocks to invest in now. Incannex Healthcare Inc. (NASDAQ:IXHL) announced on June 25 the granting of a key patent by the United States Patent and Trademark Office (USPTO) titled “Compositions and Methods of Treatment for Obstructive Sleep Apnea.” Management stated that the granted patent […] | ||